Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
April 9, 2013
Patent Application Number
12545322
Date Filed
August 21, 2009
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention relates to compounds of formula (I) and to pharmaceutically acceptable salts and pharmaceutical compositions thereof. The present invention also relates to use of the compounds of formula (I) in modulating the activity of protein kinases and in the treatment of disease, particularly a disease, disorder or syndrome associated with CDK 4 inhibition.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
